ORCHID PHARMA
Back to Cashflow Statement
|
ORCHID PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-19 Cr | ₹18 Cr | ₹-11 Cr | ₹-74 Cr | ₹-2.42 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ORCHID PHARMA ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-19 Cr |
Mar2023 | ₹18 Cr |
Mar2022 | ₹-11 Cr |
Mar2021 | ₹-74 Cr |
Mar2020 | ₹-2.42 Cr |
How is Net Cash Inflow / Outflow of ORCHID PHARMA Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-19 Cr | Negative | |
Mar2023 | ₹18 Cr | Positive | |
Mar2022 | ₹-11 Cr | Negative | |
Mar2021 | ₹-74 Cr | Negative | |
Mar2020 | ₹-2.42 Cr | - |
Compare Net Cash Inflow / Outflow of peers of ORCHID PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ORCHID PHARMA | ₹4,159.7 Cr | -2.7% | 5.6% | -26.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹440,314.0 Cr | -0.4% | 5.7% | 20.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,809.0 Cr | 1.7% | 6.2% | 52.9% | Stock Analytics | |
CIPLA | ₹124,627.0 Cr | -0.7% | 7% | 8.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,127.0 Cr | -1.6% | 1.5% | 21.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,839.9 Cr | -2.3% | 2.5% | -6% | Stock Analytics |
ORCHID PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ORCHID PHARMA | -2.7% |
5.6% |
-26.9% |
SENSEX | 2% |
4.1% |
9.6% |
You may also like the below Video Courses